132 related articles for article (PubMed ID: 6800421)
1. Distribution of plasma fibronectin (cold-insoluble globulin) and components of the factor VIII complex after heparin-induced precipitation of plasma.
Amrani DL; Mosesson MW; Hoyer LW
Blood; 1982 Mar; 59(3):657-63. PubMed ID: 6800421
[TBL] [Abstract][Full Text] [Related]
2. Factor VIII (procoagulant activity VIII:C, and antigen VIII:CAg, related antigen VIIIR:Ag and ristocetin cofactor VIIIR:Cof) in intensive care patients with clinically suspected disseminated intravascular coagulation (DIC).
Tran TH; Lämmle B; Duckert F
Am J Clin Pathol; 1984 Nov; 82(5):565-72. PubMed ID: 6437209
[TBL] [Abstract][Full Text] [Related]
3. Purification of the factor VIII complex.
Thorell L; Blombäck B
Thromb Res; 1984 Aug; 35(4):431-50. PubMed ID: 6435279
[TBL] [Abstract][Full Text] [Related]
4. Time course of changes in in vitro platelet function and plasma von willebrand factor activity (VIIIR:WF) and factor VIII-related antigen (VIIIR:Ag) in the diabetic rat.
Winocour PD; Lopes-Virella M; Laimins M; Colwell JA
J Lab Clin Med; 1983 Nov; 102(5):795-804. PubMed ID: 6415193
[TBL] [Abstract][Full Text] [Related]
5. Effect of insulin treatment in streptozocin-induced diabetic rats on in vitro platelet function and plasma von Willebrand factor activity and factor VIII-related antigen.
Winocour PD; Lopes-Virella M; Laimins M; Colwell JA
J Lab Clin Med; 1985 Sep; 106(3):319-25. PubMed ID: 3928783
[TBL] [Abstract][Full Text] [Related]
6. Factor VIII procoagulant activity, factor VIII related antigen and von Willebrand factor in newborn cord blood.
Fukui H; Takase T; Ikari H; Murakami Y; Okubo Y; Nakamura K
Br J Haematol; 1979 Aug; 42(4):637-46. PubMed ID: 314304
[TBL] [Abstract][Full Text] [Related]
7. Heterogeneity of molecular size of factor VIII/von Willebrand factor in von Willbrand's disease.
Mikami S; Takahashi Y; Nishino M; Okubo Y; Fukui H
Thromb Haemost; 1981 Jun; 45(3):272-5. PubMed ID: 6792740
[TBL] [Abstract][Full Text] [Related]
8. Dissociation of factor VIII procoagulant antigen VIII:CAg and factor VIII related antigen VIIIR:Ag by EDTA - influence of divalent cation on the binding of VIII:CAg and VIIIR:Ag.
Tran TH; Duckert F
Thromb Haemost; 1983 Aug; 50(2):547-51. PubMed ID: 6415848
[TBL] [Abstract][Full Text] [Related]
9. Destruction of ristocetin cofactor by coagulation at 4 degrees C.
Lloyd JV; Tunbridge LJ; Rodgers SE; Hondow JA; Russell WJ
Thromb Res; 1985 Mar; 37(6):659-68. PubMed ID: 3922085
[TBL] [Abstract][Full Text] [Related]
10. The role of fibronectin in factor VIII/von Willebrand factor cryoprecipitation.
Mazurier C; Samor B; Deromeuf C; Goudemand M
Thromb Res; 1985 Mar; 37(6):651-8. PubMed ID: 3922084
[TBL] [Abstract][Full Text] [Related]
11. The evaluation of factor VIII antigen by means of a simple slide test.
Casonato A; Fabris F; Vicariotto M; Girolami A
Am J Clin Pathol; 1985 Jul; 84(1):107-11. PubMed ID: 3925753
[TBL] [Abstract][Full Text] [Related]
12. [Factor VIII (coagulation activity VIII:C, antigen concentration VIIIR:Ag and von Willebrand factor) in patients with clinically expected intravascular coagulation].
Tran TH; Lämmle B; Marbet UA; Ritz R; Marbet GA; Duckert F
Schweiz Med Wochenschr; 1981 Oct; 111(41):1542-3. PubMed ID: 6797063
[TBL] [Abstract][Full Text] [Related]
13. [Factor VIII complex activities in acute leukemia].
Pniejnia-Olszyński W; Lopaciuk S
Acta Haematol Pol; 1980; 11(4):239-47. PubMed ID: 6794320
[TBL] [Abstract][Full Text] [Related]
14. Immunological evidence that human factor VIII is composed of two linked moieties.
Koutts J; Lavergne JM; Meyer D
Br J Haematol; 1977 Nov; 37(3):415-28. PubMed ID: 341960
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of factor VIII-rich cryoprecipitate and the plasma fibronectin-rich, heparin-precipitable fraction prepared from single-donor plasma units.
Menitove JE; Amrani DL; Meh D; Frenzke M; Mosesson MW
Transfusion; 1987; 27(6):491-5. PubMed ID: 3500532
[TBL] [Abstract][Full Text] [Related]
16. Changes in factor VIII complex activities during the production of a clinical intermediate purity factor VIII concentrate.
Prowse CV; Griffin B; Pepper DS; Dickson AJ; McQuillan TA; Dickson IH; Foster PR
Thromb Haemost; 1981 Oct; 46(3):597-601. PubMed ID: 6797090
[TBL] [Abstract][Full Text] [Related]
17. Von Willebrand's syndrome. Studies on a variant factor VIII.
Hill FG; Chan MC; Hardisty RM
Haemostasis; 1976; 5(5):276-84. PubMed ID: 797643
[TBL] [Abstract][Full Text] [Related]
18. Variant von Willebrand's disease: characterization of two subtypes by analysis of multimeric composition of factor VIII/von Willebrand factor in plasma and platelets.
Ruggeri ZM; Zimmerman TS
J Clin Invest; 1980 Jun; 65(6):1318-25. PubMed ID: 6773982
[TBL] [Abstract][Full Text] [Related]
19. A critical evaluation of the available methods for the determination of factor VIII von Willebrand.
Casonato A; Girolami A
Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(5):670-84. PubMed ID: 2435633
[TBL] [Abstract][Full Text] [Related]
20. Interactions among heparin, cold-insoluble globulin, and fibrinogen in formation of the heparin-precipitable fraction of plasma.
Stathakis NE; Mosesson MW
J Clin Invest; 1977 Oct; 60(4):855-65. PubMed ID: 19499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]